Compare ATRC & XPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATRC | XPRO |
|---|---|---|
| Founded | 2000 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2005 | 2026 |
| Metric | ATRC | XPRO |
|---|---|---|
| Price | $41.47 | $17.79 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | ★ $51.17 | $16.00 |
| AVG Volume (30 Days) | 895.1K | ★ 961.7K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.74 | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $201,630,000.00 | N/A |
| Revenue This Year | $15.27 | $1.86 |
| Revenue Next Year | $12.21 | $4.70 |
| P/E Ratio | $231.06 | ★ N/A |
| Revenue Growth | ★ 15.40 | N/A |
| 52 Week Low | $25.36 | $10.18 |
| 52 Week High | $43.18 | $18.73 |
| Indicator | ATRC | XPRO |
|---|---|---|
| Relative Strength Index (RSI) | 70.87 | 66.19 |
| Support Level | $39.40 | $15.14 |
| Resistance Level | $42.36 | $18.59 |
| Average True Range (ATR) | 1.79 | 0.96 |
| MACD | 0.18 | 0.18 |
| Stochastic Oscillator | 93.70 | 98.83 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Expro Group Holdings NV offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions. It also provides production optimization for both onshore and offshore applications. The company has four operating segments: North and Latin America (NLA); Europe and Sub-Saharan Africa (ESSA); Middle East and North Africa (MENA); and Asia-Pacific (APAC). The majority of its revenue is derived from the North and Latin America (NLA) segment.